Clinical Trials Directory

Trials / Completed

CompletedNCT01428349

Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
180 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This is a 2 -year NIDA funded grant (Co-PIs: Joseph P. Newman, John Curtin, and Carl Lejuez) that examines whether recent progress in characterizing the cognitive deficits associated with psychopathic and externalizing offenders may be used to develop better therapeutic interventions to treat their substance abuse and other self-control problems. Inmates with externalizing or psychopathy will receive one of two computer-based interventions to remediate the core cognitive skills that have been linked to self-regulation deficits in the two groups. One intervention (ACC) targets the affective cognitive control deficits associated with externalizing offenders whereas the other intervention (ATC) targets the attention to context deficits associated with psychopathic offenders. The specific components of the project include: selection and randomization of inmates; pre- and post-treatment behavioral and brain-related (ERP and Startle) measures to evaluate the impact and specificity of the ACC and ATC treatments; and 6 sessions of behavioral (e.g. computerized) and verbal training in ACC or ATC.

Conditions

Interventions

TypeNameDescription
OTHERCognitive RemediationComputer training on 3 tasks that targets the attention to context deficits associated with psychopathic offenders. Participants complete 6 training sessions, that include the tasks, feedback and real-world translational examples.
OTHERCognitive RemediationComputer training on 3 tasks that targets the affective cognitive control deficits associated with externalizing offenders. Participants complete 6 training sessions, that include the tasks, feedback and real-world translational examples.

Timeline

Start date
2011-05-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2011-09-05
Last updated
2015-06-02

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01428349. Inclusion in this directory is not an endorsement.